| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
Digg It - Online Brokerage
The growing online brokerage industry has become the most fashionable way to purchase and sell stocks. This fueled the act According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ions of the Securities and Exchange Commission (SEC) to allocate more of its time and resources in scrutinizing the invest ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ent products that the online brokerage industry provides. The SEC has made some mandatory requirements to the online broke lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. age industry regarding the contents of the websites, the prices of the products, the information that they disseminate to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe heir clients, and the security of the accounts of the clients. Even with these, SEC has not fully been able to impose regu d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lations that will allow clients to have access to their accounts anytime, and that the account statements generated online ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc would be the accurate representation of the clients’ assets. These are the reasons why some members of the online brokerag easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi industry have been subjects of legal actions or are the main respondents of complaints filed with the SEC. The recommenda nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ions and the advices that SEC has extended to the online brokerage industry, through its commissioner, or its compliance i and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nspectors have not been sufficient and have not made any improvements on the online brokerage industry’s system. With all ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi he loopholes in the online brokerage industry today, it should be about time that SEC gives out more than just warnings. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hether we know what they mean or not, we have to admit that we have been hearing PE ratios and financial terms in the supe dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod market or even on the streets. Let’s face it. The online brokerage industry is rising and rising every second. It is takin cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin g the world by storm. And why not? In this computer age, people have gotten so used to doing business online. And what bet tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen er way to court potential clients than wooing them online? Forecast has it that the number of households trading online in t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the U.S. will have tremendous increase from 4.1 million to a whooping 21 million in 5 years. Even with the large number o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hitches that the online brokerage industry has been in focus for, there is still a large growth in the number of people t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products hat would rather trade online. This calls for a stronger conviction of imposing stricter policies on the online brokerage . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ndustry from SEC. They have been vested with the power to do a lot more than make recommendations. Whether SEC admits it o elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip not, it has the power to implement regulations that will force any member of the online brokerage industry to comply with tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Interview Question: Why Should We Hire You? Sales Training Tips for Aircraft Sales Businesses
|